| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.3 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.3 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |